MDM2 and neoplasm: Our group has previously shown that overexpression of MDM2, leading to increased TP53 degradation, is frequently observed in medulloblastomas with wildtype TP53, and that nutlin-3, which inhibits TP53-MDM2 interaction, reduces tumor growth in vitro and in vivo [18].